Team:UESTC-China
From 2014.igem.org
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{ | + | <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"> |
+ | <html xmlns="http://www.w3.org/1999/xhtml"> | ||
+ | <head> | ||
+ | <title></title> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> | ||
+ | <meta http-equiv="Content-Style-Type" content="text/css" /> | ||
+ | <style> | ||
+ | * { | ||
+ | margin:0; | ||
+ | padding:0; | ||
+ | } | ||
+ | html, body { | ||
+ | height:100%; | ||
+ | } | ||
+ | body { | ||
+ | background:#fff; | ||
+ | font-family:Tahoma, Geneva, sans-serif; | ||
+ | font-size:100%; | ||
+ | line-height:1.125em; | ||
+ | color:#777; | ||
+ | } | ||
+ | img { | ||
+ | border:0; | ||
+ | vertical-align:top; | ||
+ | text-align:left; | ||
+ | } | ||
+ | object { | ||
+ | vertical-align:top; | ||
+ | outline:none; | ||
+ | } | ||
+ | ul, ol { | ||
+ | list-style:none; | ||
+ | } | ||
- | + | .fleft { | |
+ | float:left; | ||
+ | } | ||
+ | .fright { | ||
+ | float:right; | ||
+ | } | ||
+ | .clear { | ||
+ | clear:both; | ||
+ | } | ||
- | + | .inner_copy {border:0;color:#f00;float:left;width:50%!important;margin:-202px 0 0 0;overflow:hidden;line-height:0;padding:0;font-size:12px} | |
- | + | ||
+ | .col-1, .col-2, .col-3 { | ||
+ | float:left; | ||
+ | } | ||
- | + | .alignright { | |
- | + | text-align:right; | |
- | + | } | |
- | + | .aligncenter { | |
- | + | text-align:center; | |
- | + | } | |
- | + | .wrapper { | |
- | + | width:100%; | |
- | + | overflow:hidden; | |
+ | } | ||
+ | .container { | ||
+ | width:100%; | ||
+ | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | + | .container { | |
- | + | width:980px; | |
+ | margin:0 auto; | ||
+ | font-size:.75em; | ||
+ | position:relative; | ||
+ | } | ||
- | + | #header { | |
- | + | height:445px; | |
+ | overflow:hidden; | ||
+ | } | ||
+ | #content .mainContent { | ||
+ | float:left; | ||
+ | width:100%; | ||
+ | padding-bottom:100px; | ||
+ | position:relative; | ||
+ | } | ||
+ | #content .aside { | ||
+ | float:left; | ||
+ | width:290px; | ||
+ | display:inline; | ||
+ | } | ||
+ | #content .aside.left { | ||
+ | margin-right:54px; | ||
+ | } | ||
+ | #content .aside.right { | ||
+ | margin-left:54px; | ||
+ | } | ||
+ | #footer { | ||
+ | height:68px; | ||
+ | overflow:hidden; | ||
+ | background:url(images/footer-bg.gif) 0 0 repeat-x #358305; | ||
+ | } | ||
- | |||
- | |||
- | |||
- | |||
- | + | input, select, textarea { | |
- | + | font-family:Tahoma, Geneva, sans-serif; | |
+ | font-size:1em; | ||
+ | vertical-align:middle; | ||
+ | font-weight:normal; | ||
+ | } | ||
- | |||
- | |||
- | + | /*----- other -----*/ | |
- | + | .img-indent { | |
+ | margin:0 20px 0 0; | ||
+ | float:left; | ||
+ | } | ||
+ | .img-box { | ||
+ | width:100%; | ||
+ | overflow:hidden; | ||
+ | padding-bottom:20px; | ||
+ | } | ||
+ | .img-box img { | ||
+ | float:left; | ||
+ | margin:0 20px 0 0; | ||
+ | } | ||
- | + | .extra-wrap { | |
- | + | overflow:hidden; | |
+ | } | ||
- | |||
- | |||
+ | p { | ||
+ | margin-bottom:18px; | ||
+ | } | ||
+ | .p1 { | ||
+ | margin-bottom:9px; | ||
+ | } | ||
+ | .p2 { | ||
+ | margin-bottom:18px; | ||
+ | } | ||
+ | .p3 { | ||
+ | margin-bottom:27px; | ||
+ | } | ||
- | |||
- | |||
- | |||
- | + | a { | |
- | + | color:#f1680c; | |
- | + | outline:none; | |
- | + | } | |
+ | a:hover{ | ||
+ | text-decoration:none; | ||
+ | } | ||
- | + | h1 { | |
- | + | position:absolute; | |
- | + | left:58px; | |
+ | top:29px; | ||
+ | font-size:53px; | ||
+ | line-height:1.2em; | ||
+ | color:#000; | ||
+ | font-family:"Times New Roman", Times, serif; | ||
+ | font-style:italic; | ||
+ | } | ||
+ | h1 a { | ||
+ | color:#000; | ||
+ | text-decoration:none; | ||
+ | } | ||
+ | h1 a span { | ||
+ | color:#f86607; | ||
+ | font-size:39px; | ||
+ | font-weight:normal; | ||
+ | } | ||
+ | h2 { | ||
+ | font-family:"Times New Roman", Times, serif; | ||
+ | font-size:28px; | ||
+ | line-height:1.2em; | ||
+ | font-weight:normal; | ||
+ | color:#000; | ||
+ | font-style:italic; | ||
+ | margin-bottom:20px; | ||
+ | } | ||
+ | h2 strong { | ||
+ | color:#f04809; | ||
+ | } | ||
+ | h3 { | ||
+ | font-family:"Times New Roman", Times, serif; | ||
+ | font-size:27px; | ||
+ | font-weight:normal; | ||
+ | font-style:italic; | ||
+ | color:#fff; | ||
+ | background:url(images/title-bg.jpg) no-repeat 0 0; | ||
+ | width:290px; | ||
+ | height:46px; | ||
+ | line-height:46px; | ||
+ | text-indent:21px; | ||
+ | text-shadow:0 0 4px #ca591c; | ||
+ | position:relative; | ||
+ | z-index:2; | ||
+ | } | ||
- | + | .link1 { | |
- | + | font-weight:bold; | |
- | + | color:#348e00; | |
- | + | } | |
- | + | .extra-box { | |
- | + | background:url(images/igem.png) no-repeat 0 0; | |
- | + | width:600px; | |
- | + | height:220px; | |
- | + | margin-bottom:30px; | |
- | + | } | |
- | + | .extra-box .inner { | |
- | + | padding:20px 195px 0 25px; | |
- | + | } | |
- | + | .extra-box h2 { | |
- | + | font-size:32px; | |
+ | line-height:1em; | ||
+ | } | ||
+ | .extra-box h2 strong { | ||
+ | font-weight:normal; | ||
+ | color:#0075d2; | ||
+ | } | ||
+ | .extra-box h2 i { | ||
+ | display:block; | ||
+ | font-size:25px; | ||
+ | line-height:1.2em; | ||
+ | font-weight:bold; | ||
+ | margin-bottom:-10px; | ||
+ | } | ||
+ | .extra-box h2 i strong { | ||
+ | font-weight:bold; | ||
+ | color:#0075d2; | ||
+ | } | ||
+ | .extra-box p { | ||
+ | width:180px; | ||
+ | } | ||
+ | .extra-box a { | ||
+ | font-family:"Times New Roman", Times, serif; | ||
+ | font-style:italic; | ||
+ | font-weight:bold; | ||
+ | text-decoration:none; | ||
+ | color:#f04809; | ||
+ | font-size:18px; | ||
+ | line-height:1.2em; | ||
+ | } | ||
- | |||
+ | .address { | ||
+ | float:left; | ||
+ | } | ||
+ | .address dt { | ||
+ | background:none; | ||
+ | margin:0 0 16px 0; | ||
+ | color:#777; | ||
+ | padding:0; | ||
+ | font-weight:normal; | ||
+ | } | ||
+ | .address dd { | ||
+ | clear:both; | ||
+ | padding:0; | ||
+ | margin:0; | ||
+ | background:none; | ||
+ | border:none; | ||
+ | } | ||
+ | .address dd span { | ||
+ | float:left; | ||
+ | width:82px; | ||
+ | } | ||
- | + | .departments { | |
- | + | float:left; | |
- | + | margin-top:-16px; | |
- | + | padding:12px 0 20px 0; | |
- | + | } | |
- | + | .departments dt { | |
- | + | margin-bottom:16px; | |
- | + | background:none; | |
- | + | padding:16px 0 0 0; | |
- | + | margin:0; | |
+ | color:#777; | ||
+ | } | ||
+ | .departments dd { | ||
+ | clear:both; | ||
+ | padding:0; | ||
+ | margin:0; | ||
+ | background:none; | ||
+ | border:none; | ||
+ | } | ||
+ | .departments dd span { | ||
+ | float:left; | ||
+ | width:82px; | ||
+ | } | ||
- | |||
- | + | #header .row-1 { | |
- | + | height:122px; | |
- | + | overflow:hidden; | |
- | + | background:url(images/header-tail-1.gif) 0 0 repeat-x; | |
+ | } | ||
+ | #header .row-1 .rss { | ||
+ | /*display:block;*/ | ||
+ | position:absolute; | ||
+ | right:22px; | ||
+ | top:42px; | ||
+ | bottom:40px; | ||
+ | } | ||
+ | #header .row-2 { | ||
+ | height:57px; | ||
+ | overflow:hidden; | ||
+ | background:url(images/header-tail-2.gif) 0 0 repeat-x; | ||
+ | } | ||
+ | #header .nav { | ||
+ | padding:10px 0 0 0; | ||
+ | } | ||
+ | #header .nav li { | ||
+ | float:left; | ||
+ | background:url(images/divider.gif) no-repeat 0 0; | ||
+ | padding:0 40px 0 41px; | ||
+ | } | ||
+ | #header .nav li.first { | ||
+ | background:none; | ||
+ | padding:0 40px 0 85px; | ||
+ | } | ||
+ | #header .nav li a { | ||
+ | float:left; | ||
+ | padding:10px 0 10px 0; | ||
+ | font-family:"Times New Roman", Times, serif; | ||
+ | font-size:21px; | ||
+ | font-style:italic; | ||
+ | text-decoration:none; | ||
+ | color:#646c71; | ||
+ | } | ||
+ | #header .nav li a:hover, #header .nav li a.current { | ||
+ | color:#000; | ||
+ | text-shadow:0 0 3px #fff; | ||
+ | } | ||
+ | #header .row-3 { | ||
+ | height:266px; | ||
+ | overflow:hidden; | ||
+ | background:url(images/header-tail-3.gif) 0 0 repeat-x; | ||
+ | } | ||
+ | .banner { | ||
+ | background:url(images/banner.jpg) no-repeat 0 0; | ||
+ | width:340px; | ||
+ | height:242px; | ||
+ | position:absolute; | ||
+ | right:38px; | ||
+ | top:24px; | ||
+ | font-size:28px; | ||
+ | line-height:1.2em; | ||
+ | font-family:"Times New Roman", Times, serif; | ||
+ | color:#000; | ||
+ | font-style:italic; | ||
+ | } | ||
+ | .banner .inner { | ||
+ | padding:60px 35px 0 63px; | ||
+ | } | ||
+ | .banner strong { | ||
+ | display:block; | ||
+ | font-size:36px; | ||
+ | color:#f06009; | ||
+ | } | ||
+ | .banner a { | ||
+ | font-size:21px; | ||
+ | text-decoration:none; | ||
+ | color:#479c0f; | ||
+ | display:block; | ||
+ | text-align:center; | ||
+ | margin-top:27px; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | .banner a:hover { | ||
+ | color:#000; | ||
+ | text-decoration:underline; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | #header .text-box { | ||
+ | padding:47px 385px 0 57px; | ||
+ | color:#2d4e18; | ||
+ | } | ||
+ | #header .text-box h2 { | ||
+ | color:#153102; | ||
+ | margin-bottom:11px; | ||
+ | } | ||
+ | #header .text-box h2 strong { | ||
+ | color:#fff; | ||
+ | } | ||
+ | #header .text-box a { | ||
+ | color:#fff; | ||
+ | } | ||
+ | |||
+ | #header .text-box ul { | ||
+ | padding-bottom:13px; | ||
+ | } | ||
+ | #header .text-box ul li { | ||
+ | background:url(images/bull1.gif) no-repeat 0 9px; | ||
+ | padding:0 0 6px 13px; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | #header .text-box ul li a { | ||
+ | color:#a8fc74; | ||
+ | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | + | #content .indent { | |
+ | padding:47px 56px 51px 54px; | ||
+ | } | ||
+ | #content .article { | ||
+ | padding-bottom:40px; | ||
+ | } | ||
+ | #content .nav { | ||
+ | position:absolute; | ||
+ | left:0; | ||
+ | bottom:0; | ||
+ | width:522px; | ||
+ | border-top:1px solid #d4d4d4; | ||
+ | text-align:center; | ||
+ | padding:25px 0 0 0; | ||
+ | } | ||
+ | #content .nav li { | ||
+ | display:inline; | ||
+ | background:none; | ||
+ | padding:0; | ||
+ | } | ||
+ | #content .nav li a { | ||
+ | color:#777; | ||
+ | text-decoration:none; | ||
+ | padding:0 17px 0 20px; | ||
+ | } | ||
+ | #content .nav li a:hover { | ||
+ | color:#000; | ||
+ | text-decoration:underline; | ||
+ | } | ||
+ | #content ul { | ||
+ | padding-bottom:11px; | ||
+ | } | ||
+ | #content ul li { | ||
+ | background:url(images/bull-2.gif) no-repeat 0 7px; | ||
+ | padding:0 0 7px 13px; | ||
+ | position:relative; | ||
+ | } | ||
+ | |||
+ | dl dt { | ||
+ | background:url(images/marker1.gif) no-repeat 0 4px; | ||
+ | padding:4px 0 19px 41px; | ||
+ | font-weight:bold; | ||
+ | color:#348e00; | ||
+ | } | ||
+ | dl dd { | ||
+ | border-bottom:1px dashed #cfcfcf; | ||
+ | padding-bottom:20px; | ||
+ | margin-bottom:20px; | ||
+ | } | ||
+ | dl dd strong { | ||
+ | color:#f04809; | ||
+ | } | ||
- | + | /*===== footer =====*/ | |
- | + | #footer { | |
+ | color:#254c12; | ||
+ | } | ||
+ | #footer a { | ||
+ | color:#6afa0c; | ||
+ | } | ||
+ | #footer .indent { | ||
+ | padding:25px 0 0 52px; | ||
+ | } | ||
- | |||
+ | /*----- forms -----*/ | ||
+ | #contacts-form fieldset { | ||
+ | border:none; | ||
+ | width:100%; | ||
+ | overflow:hidden; | ||
+ | display:block; | ||
+ | } | ||
+ | #contacts-form .col-1 { | ||
+ | width:247px !important; | ||
+ | margin-right:0 !important; | ||
+ | } | ||
+ | #contacts-form .col-2 { | ||
+ | width:274px !important; | ||
+ | margin-right:0 !important; | ||
+ | } | ||
+ | #contacts-form label { | ||
+ | display:block; | ||
+ | height:46px; | ||
+ | overflow:hidden; | ||
+ | } | ||
+ | #contacts-form input { | ||
+ | color:#111; | ||
+ | border:1px solid #b1b1b1; | ||
+ | background:none; | ||
+ | padding:2px 0 2px 5px; | ||
+ | width:205px; | ||
+ | } | ||
+ | #contacts-form textarea { | ||
+ | color:#111; | ||
+ | border:1px solid #b1b1b1; | ||
+ | background:none; | ||
+ | padding:2px 0 2px 5px; | ||
+ | width:268px; | ||
+ | overflow:auto; | ||
+ | height:107px; | ||
+ | margin-bottom:18px; | ||
+ | } | ||
+ | .v{ | ||
+ | position:relative; | ||
+ | float:left; | ||
+ | } | ||
+ | .vlinks{ | ||
+ | position:relative; | ||
+ | float:right;} | ||
- | </ | + | </style> |
+ | <!--[if lt IE 7]> | ||
+ | <link href="ie_style.css" rel="stylesheet" type="text/css" /> | ||
+ | <![endif]--> | ||
+ | </head> | ||
+ | |||
+ | <body id="page1"> | ||
+ | <!-- header --> | ||
+ | <div id="header"> | ||
+ | <div class="row-1"> | ||
+ | <div class="container"> | ||
+ | <h1><a href="index.html">UESTC-<span>China</span></a></h1> | ||
+ | <a href="2014igem.org" class="rss"><img src="images/igem.png" alt="" /></a> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row-2"> | ||
+ | <div class="container"> | ||
+ | <!-- .nav --> | ||
+ | <ul class="nav"> | ||
+ | <li class="first"><a href="index.html" class="current">Home</a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:UESTC-China/Team">Team</a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:UESTC-China/Project">Project</a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:UESTC-China/Parts">Parts</a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:UESTC-China/Modeling">Modeling</a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:UESTC-China/Notebook">Notebook</a></li> | ||
+ | <li><a href="index-5.html">Safety</a></li> | ||
+ | <li><a href="index-5.html">Attributions</a></li> | ||
+ | </ul> | ||
+ | <!-- /.nav --> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row-3"> | ||
+ | <div class="container"> | ||
+ | <div class="text-box"> | ||
+ | <h2><strong>Welcome</strong> to Our Wiki!</h2> | ||
+ | <p>we will use plant to degrade HCOH.</p> | ||
+ | |||
+ | </div> | ||
+ | <!-- .banner --> | ||
+ | <div class="banner"> | ||
+ | <div class="inner"> | ||
+ | <strong> HCOH</strong> | ||
+ | PLANT | ||
+ | <strong> HCOH</strong> | ||
+ | <a href="#">click here ></a> | ||
+ | </div> | ||
+ | </div> | ||
+ | <!-- /.banner --> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <!-- content --> | ||
+ | <div id="content"> | ||
+ | <div class="inner_copy">More from<a href="http://www.mycodes.net/" title="网页模板">网页模板</a></div> | ||
+ | <div class="container"> | ||
+ | <div class="indent"> | ||
+ | <div class="wrapper"> | ||
+ | <div class="mainContent"> | ||
+ | <!-- .extra-box --> | ||
+ | |||
+ | <h2><strong>Project</strong> Overview</h2> | ||
+ | <div class="img-box"> | ||
+ | <img src="images/igem.png" alt="" /> | ||
+ | <strong>some text</strong> introduction of our projectCancer globally kills eight million people each year, a number unchanged over the past five decades. The current paradigm for cancer treatment involves non-specific therapies such as chemotherapy and radiation that cannot differentiate between cancerous and healthy tissue. Scientists in the rising field of cancer immunotherapy are applying bionanomedical techniques to harness the patient’s own immune system to fight cancer. During primary tumor development, a patient’s innate immune function is active. However, tumors have developed a multitude of immune system inhibitors, which suppress a patient’s immune system and promote complete tumor development. We propose a novel vaccine delivery system (BactoVax) of tumor associated antigens and immunomodular agents encapsulated within probiotic bacteria, akin to those found in commercial yogurt. The proposed vaccine should breach the immunological barrier posed by primary tumors through the activation of macrophages and dendritic cells (DCs) in order to teach a patient’s immune system to recognize cell surface antigens and markers that distinguish tumors from healthy tissue. This process of “training” the immune system to target cancer stems from the adaptive immune function, which exploits the molecular properties of cytotoxic T lymphocyte. | ||
+ | </div> | ||
+ | |||
+ | <p><strong>some text</strong> adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl.</p> | ||
+ | |||
+ | |||
+ | </div> | ||
+ | <!-- yan | ||
+ | <div class="aside right"> | ||
+ | <h3>Latest News</h3> | ||
+ | |||
+ | <div class="box"> | ||
+ | <dl> | ||
+ | <dt>July 18, 2008</dt> | ||
+ | <dd><strong>Lorem ipsum</strong> sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut. <a href="#"><img src="images/arrow1.gif" alt="" /></a></dd> | ||
+ | <dt>July 18, 2008</dt> | ||
+ | <dd><strong>Lorem ipsum dolor set</strong> sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut. <a href="#"><img src="images/arrow1.gif" alt="" /></a></dd> | ||
+ | <dt>July 18, 2008</dt> | ||
+ | <dd><strong>Lorem ipsum dolor</strong> sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut. <a href="#"><img src="images/arrow1.gif" alt="" /></a></dd> | ||
+ | <dt>July 18, 2008</dt> | ||
+ | <dd><strong>Magna set ipsum dolor</strong> sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut. <a href="#"><img src="images/arrow1.gif" alt="" /></a></dd> | ||
+ | </dl> | ||
+ | <a href="#" class="link1">all news</a> | ||
+ | </div> | ||
+ | yan --> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <!-- footer --> | ||
+ | <div id="footer"> | ||
+ | <div class="container"> | ||
+ | <div class="indent"> | ||
+ | <div class="v">Sponsers<a href="index-6.html">UESTC</a> UESTC <a href="http://www.mycodes.net/" target="_blank" title="UESTC">UESTC</a></div><!-- VLinks --> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </body> | ||
</html> | </html> |
Revision as of 12:58, 10 June 2014
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
More from网页模板
Project Overview
some text introduction of our projectCancer globally kills eight million people each year, a number unchanged over the past five decades. The current paradigm for cancer treatment involves non-specific therapies such as chemotherapy and radiation that cannot differentiate between cancerous and healthy tissue. Scientists in the rising field of cancer immunotherapy are applying bionanomedical techniques to harness the patient’s own immune system to fight cancer. During primary tumor development, a patient’s innate immune function is active. However, tumors have developed a multitude of immune system inhibitors, which suppress a patient’s immune system and promote complete tumor development. We propose a novel vaccine delivery system (BactoVax) of tumor associated antigens and immunomodular agents encapsulated within probiotic bacteria, akin to those found in commercial yogurt. The proposed vaccine should breach the immunological barrier posed by primary tumors through the activation of macrophages and dendritic cells (DCs) in order to teach a patient’s immune system to recognize cell surface antigens and markers that distinguish tumors from healthy tissue. This process of “training” the immune system to target cancer stems from the adaptive immune function, which exploits the molecular properties of cytotoxic T lymphocyte.
some text adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl.